Hepatitis C Virus (HCV) is the main causative agent of chronic posttransfusion hepatitis and poses an elevated risk for development of liver cirrhosis and hepatocellular carcinoma (2, 6, 28) . Much effort has been undertaken to establish therapeutic strategies against HCV infection. Both duration of and sustained response to the current standard therapy regimens are strongly associated with the HCV genotype (3, 10, 12, 30) . For this reason, besides quantitative PCR, genotyping has become increasingly important in laboratory routine diagnostics. The most-effective way to determine these two parameters would be the usage of the same amplicons for diagnostic HCV RNA detection and for genotyping (19) .
The demand for quantitative assays to monitor the viral load during antiviral therapy (8, 12) has led to the development of a variety of amplification procedures. Recently, we have developed a LightCycler assay which fulfils the need for fast real-time quantitative detection of HCV RNA (21) . To meet the increasing need for fast and easily performable genotyping assays, we have developed a genotyping method using LightCycler technology. Amplicons of the 5Ј noncoding region, which are generated during the routine determination of the quantitative viral load, are used for genotyping by fluorophorelabeled oligonucleotides. The results obtained by this new assay were compared to those obtained by nucleotide sequencing, which is currently regarded as the "gold standard" (23) .
MATERIALS AND METHODS
Serum samples. Sera from 190 chronically HCV infected patients were included in the retrospective study. The samples were selected for their genotype, which had been determined prior to the study by nucleotide sequencing according to the system proposed by Simmonds and coworkers (23) . The enrolled collection represents the distribution of the main HCV genotypes in the United States and Europe (18, 20) and consisted of 1a isolates (n ϭ 35), 1b isolates (n ϭ 52), 2a isolates (n ϭ 13), 2b isolates (n ϭ 17), 2c isolates (n ϭ 3), 3a isolates (n ϭ 62), 4a isolates (n ϭ 15), and one 4c isolate.
Samples derived from 30 healthy blood donors served as negative controls. LightCycler PCR. LightCycler PCR was performed as recently described (21) with slight modifications. Nucleic acids were extracted automatically by MagNA Pure (Roche Molecular Biochemicals, Indianapolis, Ind.). Reverse transcription and PCR were performed in a single step using Tth (LightCycler RNA Master SYBR Green I Kit) containing 3.25 mM Mn acetate by using 5 pmol each of primers 27 (5Ј-TCCACCATGAATCACTCCC-3Ј; positions 27 to 43 according to numbering of nucleotide sequences as previously described [2] ) and KY81as (5Ј-CGGAACCGGTGAGTACACC-3Ј; positions 169 to 150). PCR was performed in 45 cycles with 1 s at 95°C (denaturation), 3 s at 55°C (annealing), and 8 s at 72°C (extension), and fluorescence detection was performed by melting point (T m ) curve analysis. Results were expressed as international units per milliliter according to different standards as described previously (21) . After completing PCR, 2 l was diluted in 198 l of H 2 O, and 2 l of this dilution was used for genotyping.
LightCycler typing. PCR was performed using 2 l of LightCycler-DNA Master Hybridization Probes (LightCycler-DNA Master Hybridization Probes Kit; Roche Diagnostics GmbH, Mannheim, Germany) with 3 mM MgCl 2 by using 5 pmol each of primers 27 and KY81as. For genotype detection 3 pmol of each hybridization probe was added to the reaction mixture. The position and sequences of the hybridization probes are shown in (Table 1) .
Nucleotide sequencing. Determination of genotypes and subtypes by nucleotide sequencing had been performed as previously described (5). Sequencing was performed using an ABI Prism 310 Genetic Analyzer (PE Applied Biosystems, Weiterstadt, Germany). The sequencing reaction was performed as recommended by the manufacturer (PE Applied Biosystems). Genotypes were determined by comparison with published reference sequences according to the classification proposed by Simmonds and coworkers (23) .
Statistical analysis. The mean values and confidence intervals were calculated using the WinSTAT program package (Springer Electronic Media, Heidelberg, Germany). For statistical analysis of the differences between the respective HCV genotypes, Student's t test was used. To estimate the reproducibility of the assay, three repeated measures of different samples were compared statistically using the Friedman test.
RESULTS
HCV genotypes of samples from 190 chronically infected patients were determined by nucleotide sequencing according to the system proposed by Simmonds and coworkers (23) .
Among the genotypes determined, 44% (n ϭ 87) belonged to genotype 1, 17% (n ϭ 33) belonged to genotype 2, 31% (n ϭ 62) belonged to genotype 3, and 8% (n ϭ 16) belonged to genotype 4. All of these samples were tested by the new LightCycler typing method. Concordant results were obtained with all 190 samples.
Quantitative viral titers in these samples ranged from 10 3 to 9 ϫ 10 6 IU/ml, representing the dynamic range described earlier for the LightCycler HCV PCR (21) . No differences regarding the titers were observed between the respective genotypes. A detection limit of 10 3 IU/ml was identical for all genotypes by LightCycler PCR and LightCycler typing assay.
T m analysis was performed, and the fluorescence signals were first measured in F2 for LC Red 640 emission. Genotypes 1 and 3 displayed similar T m s, but genotype 2 and genotype 4 isolates could easily be determined by their different T m s (Fig.  2A) . For better discrimination of type 1 and 3 isolates, T m s were additionally determined using measurement of LC Red 705 emission in F3. Signals were exclusively obtained with genotype 3 isolates as shown in Fig. 2B . Samples with T m s in the typical range for type 1 and 3 isolates in F2 and no signal in F3 belonged to genotype 1.
The mean T m s and the 95% confidence intervals of the respective genotypes are shown in Table 1 . In no case was an overlap of T m s between the respective genotypes observed. Statistical analysis using Student's t test revealed that the T m s of each of the respective genotypes 1, 2, 3, and 4 differ significantly (P Ͻ 0.001) when measured in F2.
Likewise, reproducibility of the LightCycler typing method
Comparison of nucleotide sequences of the region used for LightCycler typing. Numbering of nucleotide sequences is as previously described (2) . Dots indicate identical nucleotides between the different subtypes. In the boxes at the top of the figure, the sequences and positions of the hybridization probes are indicated. In parentheses is indicated which HCV genotype is detectable by the respective oligonucleotide. 
DISCUSSION
A new rapid PCR-based HCV genotyping method was developed using the LightCycler technology. Recently, a method using LightCycler technology for the detection and quantification of HCV RNA in serum samples was described by our group (21) . As there is evidence that the HCV genotype is one of the main factors determining the outcome of antiviral therapy (3, 10, 12, 30) . there is an increasing demand for fast and highly reproducible genotyping assays. Nucleotide sequencing is currently regarded as the reference method for genotyping of HCV isolates. However, this procedure is not considered suitable for routine laboratory settings because it is very laborious and time-consuming (7, 20, 22) . Therefore, several different tests like PCR with genotype-specific primers, restriction fragment length polymorphism assay, cleavase fragment length polymorphism assay, hybridization techniques (line probe assay), and serological assays have been developed for HCV genotype determination (1, 13-17, 20, 25) .
A further strategy to reduce expenditure and requirement for time is the use of only one system for both quantitative HCV PCR and genotyping as recently suggested (19) . A main problem of this approach is the need for highly conserved regions for routine PCR testing on the one hand and regions with sufficient variability for genotype discrimination on the other hand. The currently accepted typing system is based on nucleotide sequences of the NS-5B region of HCV (23) . Due to its variability this region is not suitable for routine PCR testing. When using other genomic regions for genotyping, misclassifications may arise due to inconstancies in the viral genome. However, a consistent feature of studies evaluating typing methods using different regions of HCV is that sequence relationships between subgenomic regions always reflect those of the complete genome (24, 26) .
For quantitative HCV RNA determination, the 5Ј noncoding region is the preferred area, because it is highly conserved. This region was chosen for the development of the LightCycler typing assay because it has been described as a useful target for both quantitative LightCycler PCR (21) and HCV genotyping by in-house tests and commercially available assays like the INNO-LiPA HCV II LineProbe assay (9, 19, 27) . By using three pairs of hybridization probes, differentiation of the genotypes is possible in a single reaction. This significantly decreases time expenditure and costs and thus enables highthroughput examinations in routine settings (22 Using the LightCycler, detection of amplification products can either be performed using SYBR Green or hybridization probes. While SYBR Green has been proven useful for quantitative HCV PCR (21), differentiation of HCV genotypes can be accomplished using different hybridization probes. Until now, only two different acceptor fluorophores have been developed to be used with the LightCycler. Therefore, the number of genotypes identifiable by this assay is restricted, and no subtypes can be distinguished so far. However, by far the prevailing HCV genotypes of Europe and the United States (18, 20) could be included. The prevalence of other genotypes is very low in our patient population. In our laboratory we found only two genotype 5 isolates and one genotype 6 isolate among specimens from more than 3,000 HCV infected patients (data not shown). From the clinical point of view, the knowledge of the precise HCV subtype seems to be unnecessary for therapeutic decisions. In this context it is most important to determine the genotype and to discriminate between genotype 1 and non-1 types (11, 19) . Patients infected with genotype 1 isolates seem to have a less favorable response to antiviral treatment than those infected with genotype 2 or 3 (4, 29) and need a different therapy regimen (30) .
Our assay revealed a wide dynamic range that extended over a 4-log range of HCV input.
One striking advantage of the LightCycler typing method is the speed with which amplification and detection of amplicons are achieved. Within about 4 h, including RNA extraction, both the quantitative PCR and genotyping can be performed.
